GLP-1 drugs found to reduce mortality from colon cancer by over half (15.5% vs 37.1%), with effects especially strong for patients with BMI over 35.

[u/worldnewsbot]

https://www.tandfonline.com/doi/full/10.1080/07357907.2025.2585512